Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| K23AT009896 | U.S. NIH Grant/Contract | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| National Center for Complementary and Integrative Health (NCCIH) | NIH |
Not provided
Not provided
Not provided
Not provided
The overarching goal is to utilize a randomized control design to examine acceptability, feasibility, and adherence of mindfulness-based stress reduction plus prenatal sleep supplement (MBSR+PS) compared to treatment as usual among pregnant people with poor sleep quality (n=50).
Poor sleep quality is highly prevalent during pregnancy, with important implications for maternal and infant health and well-being. Despite this, there is limited research on interventions to improve prenatal sleep, and prior research did not target the specific factors contributing to poor sleep quality in this population. Specifically, pregnant people report that physical symptoms, including discomfort and pain, disturb their sleep. In non-pregnant populations, this pain-sleep relationship is bidirectional, and maladaptive psychological responses to pain further exacerbate poor sleep. Theory and empirical evidence indicate that mindfulness-based interventions may be effective for targeting these psychological responses. The overarching goal is to utilize a randomized control design to examine acceptability, feasibility, and adherence of mindfulness-based stress reduction plus prenatal sleep supplement (MBSR+PS) compared to treatment as usual among pregnant people with poor sleep quality (n=50). Participants will be recruited to complete study questionnaires at two timepoints during pregnancy. Participants randomized to MBSR+PS will receive usual care, will be asked to attend 8 weekly group MBSR sessions (in addition to the MBSR orientation session, 1:1 interview with the instructor, and daylong retreat) and 6-8 PS sessions individually or in small groups, and will complete daily sleep and home practice diaries. Participants randomized to treatment as usual will receive usual care.
The specific aims are:
There is strong conceptual basis to predict the potential benefit of this approach for pregnant people. Targeting psychological responses to poor sleep during pregnancy may have significant public health benefits.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement (MBSR+PS) | Experimental | The study intervention is standard mindfulness-based stress reduction (MBSR), which will be delivered through 8 weekly 2.5-hour sessions via video conferencing to groups of 20-30 pregnant and non-pregnant people. MBSR also consists of a 2.5-hour orientation session, a 30-minute private interview with the instructor, and an all-day retreat, all conducted via video conferencing. The supplemental prenatal sleep content will be delivered through 6-8 30-minute sessions via video conferencing either individually or to small groups, and draws material from mindfulness-based therapy for insomnia, mindfulness-based childbirth and parenting program, and cognitive behavior therapy for prenatal insomnia. |
|
| Treatment as Usual | Other | The control condition was designed to reflect standard care for insomnia patients. No limits are placed on receiving non-study treatment, including medication or psychotherapy, with the exception of asking participants to refrain from participating in non-study mindfulness practice. Use of non-study treatment will be tracked. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement | Behavioral | MBSR+PS |
|
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants With a Total Score Greater Than or Equal to 24 on the 8-item Client Satisfaction Questionnaire (CSQ-8) at 12 Weeks | The Client Satisfaction Questionnaire (CSQ-8) score ranges from 8 to 32, with high scores indicating greater satisfaction. The CSQ-8 score of participants randomized to MBSR+PS will be reported; participants randomized to TAU will not complete the CSQ-8 as the questions pertain to the MBSR+PS program. | Post-intervention, an average of 12 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| Number of Participants Who Attend at Least One Session of MBSR and the PS Supplement From Baseline to 12 Weeks | Participants can attend 0-8 sessions of MBSR and of PS. | Baseline to post-intervention, an average of 12 weeks |
| Number of Participants Completing Endpoint Measures at 12 Weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Jennifer N Felder, PhD | University of California, San Francisco | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| University of California, San Francisco | San Francisco | California | 94118 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| FG000 | Mindfulness-Based Stress Reduction Plus Prenatal Sleep Supplement (MBSR+PS) | The study intervention is standard mindfulness-based stress reduction (MBSR), which will be delivered through 8 weekly 2.5-hour sessions via video conferencing to groups of 20-30 pregnant and non-pregnant people. MBSR also consists of a 2.5-hour orientation session, a 30-minute private interview with the instructor, and an all-day retreat, all conducted via video conferencing. The supplemental prenatal sleep content will be delivered through 6-8 30-minute sessions via video conferencing either individually or to small groups, and draws material from mindfulness-based therapy for insomnia, mindfulness-based childbirth and parenting program, and cognitive behavior therapy for prenatal insomnia. Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement: MBSR+PS Treatment as Usual: TAU |
| FG001 | Treatment as Usual | The control condition was designed to reflect standard care for insomnia patients. No limits are placed on receiving non-study treatment, including medication or psychotherapy, with the exception of asking participants to refrain from participating in non-study mindfulness practice. Use of non-study treatment will be tracked. Treatment as Usual: TAU |
| Title | Milestones | Reasons Not Completed | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Overall Study |
|
Not provided
Not provided
| ID | Title | Description |
|---|---|---|
| BG000 | Mindfulness-Based Stress Reduction Plus Prenatal Sleep Supplement (MBSR+PS) | The study intervention is standard mindfulness-based stress reduction (MBSR), which will be delivered through 8 weekly 2.5-hour sessions via video conferencing to groups of 20-30 pregnant and non-pregnant people. MBSR also consists of a 2.5-hour orientation session, a 30-minute private interview with the instructor, and an all-day retreat, all conducted via video conferencing. The supplemental prenatal sleep content will be delivered through 6-8 30-minute sessions via video conferencing either individually or to small groups, and draws material from mindfulness-based therapy for insomnia, mindfulness-based childbirth and parenting program, and cognitive behavior therapy for prenatal insomnia. Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement: MBSR+PS Treatment as Usual: TAU |
| Units | Counts |
|---|---|
| Participants |
|
| Title | Description | Population Description | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Denominator Units Selected | Denominators | Classes |
|---|---|---|---|---|---|---|---|---|---|
| Age, Continuous | Mean |
| Type | Title | Description | Population Description | Reporting Status | Anticipated Posting Date | Parameter Type | Dispersion Type | Unit of Measure | Calculate Percentage | Time Frame | Units Analyzed | Denominator Units Selected | Arm/Group Information | Denominators | Classes | Analyses | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Primary | Number of Participants With a Total Score Greater Than or Equal to 24 on the 8-item Client Satisfaction Questionnaire (CSQ-8) at 12 Weeks | The Client Satisfaction Questionnaire (CSQ-8) score ranges from 8 to 32, with high scores indicating greater satisfaction. The CSQ-8 score of participants randomized to MBSR+PS will be reported; participants randomized to TAU will not complete the CSQ-8 as the questions pertain to the MBSR+PS program. | The overall number of participants analyzed (n=23) is one lower than reported in the participant flow module because one participant skipped the items for this measure but completed the majority of the other endpoint surveys. | Posted | Count of Participants | Participants | Post-intervention, an average of 12 weeks |
|
Baseline to 12 weeks
Not provided
Not provided
| ID | Title | Description | Deaths (Affected) | Deaths (At Risk) | Serious Events (Affected) | Serious Events (At Risk) | Other Events (Affected) | Other Events (At Risk) |
|---|---|---|---|---|---|---|---|---|
| EG000 | Mindfulness-Based Stress Reduction Plus Prenatal Sleep Supplement (MBSR+PS) | The study intervention is standard mindfulness-based stress reduction (MBSR), which will be delivered through 8 weekly 2.5-hour sessions via video conferencing to groups of 20-30 pregnant and non-pregnant people. MBSR also consists of a 2.5-hour orientation session, a 30-minute private interview with the instructor, and an all-day retreat, all conducted via video conferencing. The supplemental prenatal sleep content will be delivered through 6-8 30-minute sessions via video conferencing either individually or to small groups, and draws material from mindfulness-based therapy for insomnia, mindfulness-based childbirth and parenting program, and cognitive behavior therapy for prenatal insomnia. Mindfulness-Based Stress Reduction plus Prenatal Sleep supplement: MBSR+PS Treatment as Usual: TAU |
Not provided
| Term | Organ System | Source Vocabulary | Assessment Type | Notes | Statistical Information |
|---|---|---|---|---|---|
| gestational diabetes dx | Pregnancy, puerperium and perinatal conditions | Systematic Assessment |
Not provided
| Title | Organization | Phone | Extension | |
|---|---|---|---|---|
| Dr. Jennifer Felder | University of California, San Francisco | 415-476-7014 | jennifer.felder@ucsf.edu |
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Nov 8, 2021 | Jun 6, 2023 | Prot_SAP_002.pdf |
Not provided
| ID | Term |
|---|---|
| D000099024 | Mindfulness-Based Stress Reduction |
| D013812 | Therapeutics |
| ID | Term |
|---|---|
| D064866 | Mindfulness |
| D015928 | Cognitive Behavioral Therapy |
| D001521 | Behavior Therapy |
| D011613 | Psychotherapy |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Treatment as Usual | Other | TAU |
|
For a measure to be considered complete, at least 95% of items must be completed. |
| Post-intervention, an average of 12 weeks |
| Completeness of Study Measures at Baseline and at 12 Weeks | For a measure to be considered complete, at least 95% of items must be completed. Completeness of study measures at baseline and 12 weeks are combined (averaged); the percentage of measures completed across timepoints is reported. | Baseline and post-intervention, an average of 12 weeks |
| Percentage of MBSR and PS Sessions Attended | This measure will not be collected for participants randomized to TAU. | Baseline to post-intervention, an average of 12 weeks |
| Frequency of Home Practices From Baseline to 12 Weeks | Participants randomized to MBSR+PS will complete daily diaries reporting their formal and informal practices. Participants randomized to TAU will not complete this measure. | Baseline to post-intervention, an average of 12 weeks |
| Duration of Home Practices From Baseline to 12 Weeks | Participants randomized to MBSR+PS will complete daily diaries reporting their formal and informal practices. Participants assigned to TAU will not complete this measure. | Baseline to post-intervention, an average of 12 weeks |
| Change in Self Compassion Scale - Short Form (SCS-SF) From Baseline to 12 Weeks | The Self Compassion Scale - Short Form (SCS-SF) score ranges from 1 to 5, with higher scores indicating greater self-compassion. The change in SCS-SF score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| Change in Five-Facet Mindfulness Questionnaire (FFMQ) Nonjudging and Nonreactivity Factors From Baseline to 12 Weeks | We included two factors of the Five-Facet Mindfulness Questionnaire (FFMQ): the nonjudging factor (score ranges from 8 to 40) and the non-reactivity factors (score ranges from 7 to 35). Higher scores indicate greater mindfulness. The change in factor scores from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| Change in Coping Strategies Questionnaire - Revised (CSQ-R) From Baseline to 12 Weeks | The Coping Strategies Questionnaire - Revised (CSQ-R) score ranges from 0 to 36 on each of the 7 subscales, with higher scores indicating greater use of a coping strategy. The change in CSQ score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| Change in Rumination-Reflection Questionnaire (RRQ) From Baseline to 12 Weeks | The Rumination-Reflection Questionnaire (RRQ) score ranges from 12 to 60 for each of the two factors. Greater scores indicate greater tendency to ruminate and reflect. The change in RRQ score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| Change in Pittsburgh Sleep Quality Index Score (PSQI) From Baseline to 12 Weeks | The Pittsburgh Sleep Quality Index (PSQI) score ranges from 0 to 21. A total score of 5 or more indicates poor sleep quality; the higher the score, the worse the sleep quality. The change in PSQI score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| Change in Insomnia Severity Index Score (ISI) From Baseline to 12 Weeks | The Insomnia Severity Index (ISI) score ranges from 0 to 28, with higher scores indicating greater insomnia severity. The change in ISI score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| Change in Dysfunctional Beliefs About Sleep Score (DBAS) From Baseline to 12 Weeks | The Dysfunctional Beliefs About Sleep (DBAS) score ranges from 0 to 10, with a score of 4 or greater indicating unrealistic expectations for sleep, and greater scores indicating more dysfunctional beliefs about sleep. The change in DBAS score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| Change in Measures for Coping With Sleep Disturbances Score From Baseline to 12 Weeks | The Measures for coping with sleep disturbances score ranges from 0 to 11, with greater scores indicating greater use of active coping measures for sleep disturbance. The change in Measures for coping with sleep disturbances score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| Worry About Sleep Duration | Single item measure that assesses whether participants worried about not getting enough sleep in the past 2 weeks. | Post-intervention, an average of 12 weeks |
| Change in Patient Health Questionnaire-9 Score (PHQ-9) From Baseline to 12 Weeks | The Patient Health Questionnaire-9 (PHQ-9) score ranges from 0 to 27, with a score greater than or equal to 10 indicating moderate to severe depression, and the higher the score, the greater the depressive symptom severity. The change in PHQ-9 score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline to post-intervention, an average of 12 weeks |
| Change in PROMIS 6-item Anxiety Score From Baseline to 12 Weeks | The PROMIS 6-item anxiety score ranges from 6 to 30, with higher scores indicating more severe anxiety; from raw scores, standardized T-scores can be determined. The change in PROMIS 6-item anxiety T-score from baseline to post-intervention (at 12 weeks) will be reported. The T-score values have a mean = 50 and SD = 10, with higher scores indicating greater anxiety. The T-scores are interpreted as follows: Less than 55 = None to slight anxiety 55.0-59.9 = Mild anxiety 60.0-69.9 = Moderate anxiety 70 and over = Severe anxiety | Baseline and post-intervention, an average of 12 weeks |
| Change in Perceived Stress Scale Score (PSS) From Baseline to 12 Weeks | The Perceived Stress Scale score ranges from 0 to 40, with higher scores indicating greater appraisal of stress. The change in PSS score from baseline to post-intervention (at 12 weeks) will be reported. | Baseline and post-intervention, an average of 12 weeks |
| BG001 | Treatment as Usual | The control condition was designed to reflect standard care for insomnia patients. No limits are placed on receiving non-study treatment, including medication or psychotherapy, with the exception of asking participants to refrain from participating in non-study mindfulness practice. Use of non-study treatment will be tracked. Treatment as Usual: TAU |
| BG002 | Total | Total of all reporting groups |
| years |
|
| Sex: Female, Male | Count of Participants | Participants |
|
| Race/Ethnicity, Customized | Count of Participants | Participants |
|
| Pittsburgh Sleep Quality Index (PSQI) Score | The Pittsburgh Sleep Quality Index (PSQI) score ranges from 0 to 21. A total score of 5 or more indicates poor sleep quality; the higher the score, the worse the sleep quality. | Mean | Standard Deviation | units on a scale |
|
|
|
| Secondary | Number of Participants Who Attend at Least One Session of MBSR and the PS Supplement From Baseline to 12 Weeks | Participants can attend 0-8 sessions of MBSR and of PS. | This measure will only be collected for the MBSR+PS group; it is not applicable for participants randomized to TAU. | Posted | Count of Participants | Participants | Baseline to post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Number of Participants Completing Endpoint Measures at 12 Weeks | For a measure to be considered complete, at least 95% of items must be completed. | Posted | Count of Participants | Participants | Post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Completeness of Study Measures at Baseline and at 12 Weeks | For a measure to be considered complete, at least 95% of items must be completed. Completeness of study measures at baseline and 12 weeks are combined (averaged); the percentage of measures completed across timepoints is reported. | Posted | Number | percentage of measures completed | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Percentage of MBSR and PS Sessions Attended | This measure will not be collected for participants randomized to TAU. | Posted | Mean | Standard Deviation | percentage of sessions attended | Baseline to post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Frequency of Home Practices From Baseline to 12 Weeks | Participants randomized to MBSR+PS will complete daily diaries reporting their formal and informal practices. Participants randomized to TAU will not complete this measure. | Participants randomized to MBSR+PS. The participant flow module lists n=24 analyzed because 24 participants completed endpoint measures. The overall number of participants analyzed for this measure is n=23 because the three participants who did not initiate MBSR+PS were not invited to complete this measure. | Posted | Mean | Standard Deviation | percentage of days | Baseline to post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Duration of Home Practices From Baseline to 12 Weeks | Participants randomized to MBSR+PS will complete daily diaries reporting their formal and informal practices. Participants assigned to TAU will not complete this measure. | Participants randomized to MBSR+PS. The participant flow module lists n=24 analyzed because 24 participants completed endpoint measures. The overall number of participants analyzed for this measure is n=23 because the three participants who did not initiate MBSR+PS were not invited to complete this measure. | Posted | Mean | Standard Deviation | number of minutes per day | Baseline to post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Self Compassion Scale - Short Form (SCS-SF) From Baseline to 12 Weeks | The Self Compassion Scale - Short Form (SCS-SF) score ranges from 1 to 5, with higher scores indicating greater self-compassion. The change in SCS-SF score from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Five-Facet Mindfulness Questionnaire (FFMQ) Nonjudging and Nonreactivity Factors From Baseline to 12 Weeks | We included two factors of the Five-Facet Mindfulness Questionnaire (FFMQ): the nonjudging factor (score ranges from 8 to 40) and the non-reactivity factors (score ranges from 7 to 35). Higher scores indicate greater mindfulness. The change in factor scores from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Coping Strategies Questionnaire - Revised (CSQ-R) From Baseline to 12 Weeks | The Coping Strategies Questionnaire - Revised (CSQ-R) score ranges from 0 to 36 on each of the 7 subscales, with higher scores indicating greater use of a coping strategy. The change in CSQ score from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Rumination-Reflection Questionnaire (RRQ) From Baseline to 12 Weeks | The Rumination-Reflection Questionnaire (RRQ) score ranges from 12 to 60 for each of the two factors. Greater scores indicate greater tendency to ruminate and reflect. The change in RRQ score from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Pittsburgh Sleep Quality Index Score (PSQI) From Baseline to 12 Weeks | The Pittsburgh Sleep Quality Index (PSQI) score ranges from 0 to 21. A total score of 5 or more indicates poor sleep quality; the higher the score, the worse the sleep quality. The change in PSQI score from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Insomnia Severity Index Score (ISI) From Baseline to 12 Weeks | The Insomnia Severity Index (ISI) score ranges from 0 to 28, with higher scores indicating greater insomnia severity. The change in ISI score from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Dysfunctional Beliefs About Sleep Score (DBAS) From Baseline to 12 Weeks | The Dysfunctional Beliefs About Sleep (DBAS) score ranges from 0 to 10, with a score of 4 or greater indicating unrealistic expectations for sleep, and greater scores indicating more dysfunctional beliefs about sleep. The change in DBAS score from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Measures for Coping With Sleep Disturbances Score From Baseline to 12 Weeks | The Measures for coping with sleep disturbances score ranges from 0 to 11, with greater scores indicating greater use of active coping measures for sleep disturbance. The change in Measures for coping with sleep disturbances score from baseline to post-intervention (at 12 weeks) will be reported. | Data were not collected for this measure. | Posted | Baseline and post-intervention, an average of 12 weeks |
|
|
| Secondary | Worry About Sleep Duration | Single item measure that assesses whether participants worried about not getting enough sleep in the past 2 weeks. | Posted | Count of Participants | Participants | Post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Patient Health Questionnaire-9 Score (PHQ-9) From Baseline to 12 Weeks | The Patient Health Questionnaire-9 (PHQ-9) score ranges from 0 to 27, with a score greater than or equal to 10 indicating moderate to severe depression, and the higher the score, the greater the depressive symptom severity. The change in PHQ-9 score from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline to post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in PROMIS 6-item Anxiety Score From Baseline to 12 Weeks | The PROMIS 6-item anxiety score ranges from 6 to 30, with higher scores indicating more severe anxiety; from raw scores, standardized T-scores can be determined. The change in PROMIS 6-item anxiety T-score from baseline to post-intervention (at 12 weeks) will be reported. The T-score values have a mean = 50 and SD = 10, with higher scores indicating greater anxiety. The T-scores are interpreted as follows: Less than 55 = None to slight anxiety 55.0-59.9 = Mild anxiety 60.0-69.9 = Moderate anxiety 70 and over = Severe anxiety | Posted | Mean | Standard Deviation | T-score | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| Secondary | Change in Perceived Stress Scale Score (PSS) From Baseline to 12 Weeks | The Perceived Stress Scale score ranges from 0 to 40, with higher scores indicating greater appraisal of stress. The change in PSS score from baseline to post-intervention (at 12 weeks) will be reported. | Posted | Mean | Standard Deviation | units on a scale | Baseline and post-intervention, an average of 12 weeks |
|
|
|
| 0 |
| 26 |
| 0 |
| 26 |
| 8 |
| 26 |
| EG001 | Treatment as Usual | The control condition was designed to reflect standard care for insomnia patients. No limits are placed on receiving non-study treatment, including medication or psychotherapy, with the exception of asking participants to refrain from participating in non-study mindfulness practice. Use of non-study treatment will be tracked. Treatment as Usual: TAU | 0 | 26 | 0 | 26 | 7 | 26 |
| COVID diagnosis | Infections and infestations | Systematic Assessment |
|
| Elevated anxiety symptoms | Psychiatric disorders | Systematic Assessment |
|
| Elevated depressive symptoms | Psychiatric disorders | Systematic Assessment |
|
| Hidradenitis | Skin and subcutaneous tissue disorders | Systematic Assessment |
|
| High blood pressure | Cardiac disorders | Systematic Assessment |
|
| Passive suicidal ideation | Psychiatric disorders | Systematic Assessment |
|
| Anemia | Blood and lymphatic system disorders | Systematic Assessment |
|
Not provided
Not provided
Not provided
| D004191 |
| Behavioral Disciplines and Activities |
| Ignoring score |
|
| Distancing score |
|
| Coping score |
|
| Praying score |
|